Skip to content Skip to sidebar Skip to footer
Subscribe Now
Viewpoint_Kimberly_Smith_2020
VIEWPOINTS
PharmaShots Interview: ViiV Healthcare’s Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Presented at IDWeek 2020
In a recent interview with PharmaShots, Kimberly Smith, MD, MPH, Head of Research & Development at ViiV Healthcare shared information on the positive findings presented at the 2020 Infectious Diseases Society of America (IDWeek) and the impact of COVID-19 on the development of long-acting cabotegravir and rilpivirine. Shots: The company reported the positive findings of a pooled…
December 28, 20200Comments
VIEWPOINTS
PharmaShots Interview: Neoleukin’s Daniel-Adriano Silva Shares Insight on Novel Protein Designed to Treat or Block SARS-COV-2
In a recent interview with PharmaShots Daniel-Adriano Silva, PhD, Co-founder and Vice President Head of Research at Neoleukin shared the significance and promise of the findings published in Science and discuss the details of its De Novo Protein Design Shots: NL-CVX1 (CTC-445.2d) demonstrated the ability to prevent infection of multiple human cell lines in vitro and to protect…
December 18, 20200Comments
Viewpoint_Noreen_Heng_2020
VIEWPOINTS
PharmaShots Interview: Kezar’s Noreen Henig Shares Insight on Therapeutic Potential of KZR-616
In a recent interview with PharmaShots, Noreen Henig, Chief Medical Officer at Kezar Life Sciences shared information on clinical and pre-clinical data supporting the potential of KZR-616 to positively affect multiple drivers of immune-mediated diseases. Shots: The poster presented at ACR 2020 includes additional patient-weeks of safety and tolerability data compared to prior data presentations for our…
December 17, 20200Comments
Viewpoint_Fabian_Gerlinghaus_2020
VIEWPOINTS
PharmaShots Interview: Cellares’ Fabian Gerlighaus Shares Insight on Cell Shuttle
In a recent interview with PharmaShots, Fabian Gerlighaus, Co-Founder and CEO of Cellares, shared information on Cellares partnership with Fred Hutchinson Cancer Research Center and unveils how the company is working to get patients the cell therapies they need. Shots: Cellares collaboration with Fred Hutchinson Cancer Research Center is a part of EAPP. Fred Hutch will work closely…
December 14, 20200Comments
Thoughtspot_Dr. Sunaina Anand
THOUGHTSPOT
Digital Biomarkers
The Healthcare industry is going through a technological revolution and it is vital for the industry to work on new technologies that will help to generate, collect & track novel data. The availability of large data makes the system becomes important to convert it into appropriate information which will helps industry researchers, clinicians, doctors, entrepreneurs,…
December 14, 20200Comments
Generics Pharma Companies Top 20 2019
TOP 20
Top 20 Generics Pharma Companies Based On 2019 Revenue
The global generics pharmaceutical market has become an intimidating segment of the pharmaceutical drug market which continuously growing and increasing with its accessibility & benefits offered as efficient and economical drugs. Generics are approved copies of small molecule drugs that contain the same amount of active ingredients- dosage form- safety- strength- route of administration- quality-…
December 10, 20200Comments